Emvita 7

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Emvita 7
Generic name
ANACARD OCC, GLANDULA SUP, LACHESIS MUTUS, LYCOPODIUM, PHOSPHORUS
Manufacturer
RUBIMED AG
Product type
HUMAN OTC DRUG
SPL set ID
45aa87c9-b12d-4eb9-aa2d-1bd800a4ee6c
SPL ID
281734b5-b1cc-74de-e063-6394a90a6e3d
Version
2
Effective date
2024-10-29
Source export date
2026-10-12
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:59:52
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: Stop use if symptoms persist or worsen. If you are pregnant or breastfeeding, consult a healthcare professional prior to use. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.